Published in Biochem Pharmacol on February 04, 2010
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats. Diabetol Metab Syndr (2014) 1.43
Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes (2014) 0.98
Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy. Indian J Endocrinol Metab (2012) 0.82
After avandia: the use of antidiabetic drugs in patients with heart failure. Tex Heart Inst J (2012) 0.81
Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway. PLoS One (2013) 0.81
Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice. Exp Diabetes Res (2011) 0.80
Milk thistle seed extract protects rat C6 astroglial cells from acute cocaine toxicity. Mol Med Rep (2014) 0.76
Dopamine modulates insulin release and is involved in the survival of rat pancreatic beta cells. PLoS One (2015) 0.76
Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study. Diabetes Care (2012) 0.75
GSK-3β mediates dexamethasone-induced pancreatic β cell apoptosis. Life Sci (2015) 0.75
Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats. PLoS One (2016) 0.75
Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence. PLoS One (2016) 0.75
Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers. Br J Clin Pharmacol (2016) 0.75
Gastrointestinal-Renal Axis: Role in the Regulation of Blood Pressure. J Am Heart Assoc (2017) 0.75
Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement. Neuropsychopharmacology (2017) 0.75
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41
Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol (1999) 2.75
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Conjugation deficient E. coli K12 F- mutants with heptose-less lipopolysaccharide. Mol Gen Genet (1976) 2.22
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf) (2009) 2.13
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11
Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia (2007) 1.94
Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res (2001) 1.91
Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol (2000) 1.89
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83
Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest (2009) 1.82
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS (2001) 1.81
Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol (2004) 1.79
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism (1991) 1.68
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol (1998) 1.67
Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells. Diabetologia (2008) 1.64
The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology (2001) 1.63
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest (1994) 1.56
CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy (2014) 1.56
Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol (2007) 1.52
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia (2011) 1.48
Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47
[Cushing's syndrome. II. New forms of treatment]. Ned Tijdschr Geneeskd (2006) 1.47
Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol (1995) 1.46
Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol (2012) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J Lipid Res (2001) 1.43
Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr (1995) 1.42
Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study. Am J Clin Nutr (2009) 1.42
Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. J Biol Chem (2001) 1.42
Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem (1993) 1.41
Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem (2000) 1.41
Anencephaly in the Netherlands: a remarkable decline. Lancet (1983) 1.41
[Abdominal obesity: metabolic complications and consequences for the liver]. Ned Tijdschr Geneeskd (2001) 1.41
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients. Atherosclerosis (1996) 1.40
[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40
[New drugs; exenatide and sitagliptin]. Ned Tijdschr Geneeskd (2008) 1.40
[Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center]. Ned Tijdschr Geneeskd (2008) 1.40
[New drugs; rimonabant]. Ned Tijdschr Geneeskd (2007) 1.39
[Acne vulgaris: endocrine aspects]. Ned Tijdschr Geneeskd (2006) 1.38
[Hirsutism]. Ned Tijdschr Geneeskd (2007) 1.38
Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol (2013) 1.36
Cushing's syndrome complicated by multiple opportunistic infections. J Endocrinol Invest (1998) 1.35
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update (2011) 1.35
Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis (1999) 1.33
Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC1 gene. Biochem Biophys Res Commun (1988) 1.31
Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction. EMBO J (2000) 1.31
Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ (1994) 1.31
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol (2001) 1.28
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis (1994) 1.28
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab (2003) 1.26
In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes (2001) 1.25
Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest (1998) 1.23
Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab (2005) 1.22
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes. J Clin Invest (1997) 1.20
Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscler Thromb Vasc Biol (1996) 1.20
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab (1990) 1.19
Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J Biol Chem (1993) 1.19
Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes (1998) 1.17
Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab (2007) 1.17
Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death. Cell Death Differ (2006) 1.15
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) (2004) 1.15
A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res (1987) 1.15
Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol (2009) 1.14
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol (2012) 1.14
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2007) 1.13
Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun (1997) 1.13
Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med (2003) 1.13
Characterization of an Escherichia coli K-12 F-Con-mutant. J Bacteriol (1976) 1.13
The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol (2007) 1.12
Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab (2008) 1.12
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab (2002) 1.11
Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes (2001) 1.10
The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J Clin Endocrinol Metab (2001) 1.10
Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab (2013) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr (2001) 1.07
Spontaneous food choice in narcolepsy. Sleep (1996) 1.07
Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice. Diabetologia (2005) 1.07
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat (1994) 1.07
Weight loss in neurodegenerative disorders. J Neurol (2009) 1.06
Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J Biol Chem (1999) 1.06
Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ (1995) 1.06
Increased basal glucose production in type 1 Gaucher's disease. J Clin Endocrinol Metab (1995) 1.05
Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab (2009) 1.05
Exophthalmos in obesity. Ophthalmic Res (2004) 1.04